+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Gene Delivery Systems - Global Strategic Business Report - Product Thumbnail Image

Gene Delivery Systems - Global Strategic Business Report

  • Report
  • April 2026
  • 196 Pages
  • Global
From
From
From
Cancer Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Immunotherapy - Global Strategic Business Report

  • Report
  • April 2026
  • 291 Pages
  • Global
From
Sarcoma Drugs - Global Strategic Business Report - Product Thumbnail Image

Sarcoma Drugs - Global Strategic Business Report

  • Report
  • April 2026
  • 126 Pages
  • Global
From
From
Metastatic Bone Disease - Global Strategic Business Report - Product Thumbnail Image

Metastatic Bone Disease - Global Strategic Business Report

  • Report
  • April 2026
  • 194 Pages
  • Global
From
Immunotherapy Drugs - Global Strategic Business Report - Product Thumbnail Image

Immunotherapy Drugs - Global Strategic Business Report

  • Report
  • April 2026
  • 193 Pages
  • Global
From
Epithelioma Treatment - Global Strategic Business Report - Product Thumbnail Image

Epithelioma Treatment - Global Strategic Business Report

  • Report
  • April 2026
  • 380 Pages
  • Global
From
From
From
Antibody Fragments - Global Strategic Business Report - Product Thumbnail Image

Antibody Fragments - Global Strategic Business Report

  • Report
  • April 2026
  • 176 Pages
  • Global
From
From
Ewing Sarcoma Market - Global Strategic Business Report - Product Thumbnail Image

Ewing Sarcoma Market - Global Strategic Business Report

  • Report
  • April 2026
  • 377 Pages
  • Global
From
From
From
From
Blood Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Blood Cancer Therapeutics - Global Strategic Business Report

  • Report
  • April 2026
  • 291 Pages
  • Global
From
Chemotherapy Treatment - Global Strategic Business Report - Product Thumbnail Image

Chemotherapy Treatment - Global Strategic Business Report

  • Report
  • April 2026
  • 188 Pages
  • Global
From
From
Loading Indicator